Overview
A 30-year-old Indian sailor presented in Italy with microcytic anemia, abdominal pain, emesis, and jaundice following months of oral Ayurvedic medication; blood lead was confirmed at 102 µg/dL on initial testing at an external hospital and 74.61 µg/dL at admission to the authors’ occupational health unit. ICP-MS analysis of the four Ayurvedic product samples identified extremely high concentrations of lead and mercury in three of four preparations, with lead reaching 23,043 mg/kg and mercury reaching 145,711 mg/kg, concentrations orders of magnitude above the highest reported soil values for the patient’s home region in Uttar Pradesh, India. The patient required three EDTA chelation cycles; blood lead at discharge was 36.27 µg/dL.
Key numbers
- Blood lead at first external evaluation: 102 µg/dL; at admission to occupational health unit: 74.61 µg/dL; urinary lead at admission: 94.7 µg/L; blood lead at discharge after three chelation cycles: 36.27 µg/dL.
- Ayurvedic product concentrations by ICP-MS (mg/kg):
- Product 1: Pb 2.31, Hg 2.54, As 0.35
- Product 2A: Pb 12,638.54, Hg 89,076.70, As 134.94
- Product 2B: Pb 23,043.02, Hg 126,640.27, As 103.98
- Product 2C: Pb 21,352.97, Hg 145,710.64, As 122.30
- Comparable highest soil concentrations for Uttar Pradesh (literature): Pb 520 mg/kg, Hg 0.49 mg/kg, As 12 mg/kg.
- Occupational exposure excluded: blood and urinary lead in three crew members were normal; >150 shipboard products tested lead-free.
- Patient dose: approximately one tablespoon of product 1 mixed with one tablespoon each of products 2A, 2B, and 2C, twice daily.
Methods (brief)
ICP-MS on 0.5 g product samples after nitric acid digestion (80°C furnace, 1 hour) and 1:1000 dilution; analytes: As, Hg, Cu, Cr, Mn, Fe, Ni, Pb. Clinical biomarkers: blood and urinary lead by ICP-MS, ALA dehydratase, ZPP, hemoglobin, liver enzymes, bilirubin. Treatment: EDTA 2 g IV day 1, then 1 g/day for 4 days per cycle, three cycles total. Case report design; no quantified daily dose of each product reported.
Implications
Certification: Ayurvedic supplements containing Rasa Shastra-style metal-added preparations (bhasmas, rasas) can deliver lead and mercury at concentrations that are 10,000-fold higher than regulatory food limits. HMT&C assessments of TCM, Ayurvedic, or other traditional medicine-derived supplements must screen for intentionally added metals, not only environmental contamination. This case illustrates that high-mercury concentrations in a supplement may not cause mercury-specific toxicity if the mercury form (inorganic) has low gastrointestinal absorption, while lead toxicity can be severe and acute.
Courses: Illustrates the supplement safety gap for traditional medicines regulated as food supplements in Western jurisdictions; contrasts intentional metal addition (Rasa Shastra philosophy) with accidental environmental contamination. Also relevant to speciation: the absence of mercury-specific symptoms despite extremely high mercury in the supplement is consistent with poor intestinal absorption of inorganic Hg forms.
App: Ayurvedic and traditional Indian medicine supplements should be flagged as high-risk matrices for Pb, Hg, and As regardless of natural or traditional status.
Wiki pages updated on ingest
Update history
The five most recent substantive edits to this page, classified major (evidence or structure moved), correction (a published value or statement was wrong and has been fixed), or minor (narrative rewritten without changing the underlying evidence). Each description is derived from what the edit did to this page; the linked commit is the authoritative record, routine regeneration passes are excluded, and the full version history lives in git. When DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.
| Commit | Date | Change | Description |
|---|---|---|---|
| e317189 | 2026-08-11 | correction | 6 sections added; narrative text revised |